Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1989 Sep;26(9):553–559. doi: 10.1136/jmg.26.9.553

Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

E Bakker 1, H Veenema 1, J T Den Dunnen 1, C van Broeckhoven 1, P M Grootscholten 1, E J Bonten 1, G J van Ommen 1, P L Pearson 1
PMCID: PMC1015693  PMID: 2810338

Abstract

In 288 Dutch and Belgian Duchenne and Becker muscular dystrophy families, the parental origin of 41 new deletion or duplication mutations was determined. Twenty seven of the new mutations occurred in the maternal X chromosome and nine in the grandmaternal and five in the grandpaternal X chromosome. The grandparental data are compatible with equal mutation rates for DMD in male and female X chromosomes. New mutations were defined by their presence in one or more progeny and absence in the lymphocytes of the mother or the grandparents. In one family a fraction of the maternal lymphocytes was found to carry the mutation, suggesting somatic mosaicism. In six cases out of 41, the mutation was transmitted more than once by a parent in whom the mutation was absent in lymphocytes, suggesting gonadal mosaicism as the explanation for the multiple transmission. Using our data for the recurrence of the mutations among the total of at risk haplotypes transmitted, we arrive at a recurrence risk of 14% for the at risk haplotype. The observation of this high risk of germinal mosaicism is crucially important for all physicians counselling females in DMD families. Recently, germinal mosaicism has been observed also in a number of other X linked and autosomal disorders. The implications and appropriate diagnostic precautions are discussed.

Full text

PDF
553

Images in this article

556Image
on p.556
556Image
on p.556
557Image
on p.557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker E., Bonten E. J., De Lange L. F., Veenema H., Majoor-Krakauer D., Hofker M. H., Van Ommen G. J., Pearson P. L. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet. 1986 Dec;23(6):573–580. doi: 10.1136/jmg.23.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakker E., Hofker M. H., Goor N., Mandel J. L., Wrogemann K., Davies K. E., Kunkel L. M., Willard H. F., Fenton W. A., Sandkuyl L. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet. 1985 Mar 23;1(8430):655–658. doi: 10.1016/s0140-6736(85)91325-x. [DOI] [PubMed] [Google Scholar]
  3. Bakker E., Van Broeckhoven C., Bonten E. J., van de Vooren M. J., Veenema H., Van Hul W., Van Ommen G. J., Vandenberghe A., Pearson P. L. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature. 1987 Oct 8;329(6139):554–556. doi: 10.1038/329554a0. [DOI] [PubMed] [Google Scholar]
  4. Byers P. H., Tsipouras P., Bonadio J. F., Starman B. J., Schwartz R. C. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. Am J Hum Genet. 1988 Feb;42(2):237–248. [PMC free article] [PubMed] [Google Scholar]
  5. Darras B. T., Francke U. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature. 1987 Oct 8;329(6139):556–558. doi: 10.1038/329556a0. [DOI] [PubMed] [Google Scholar]
  6. Darras B. T., Harper J. F., Francke U. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy. N Engl J Med. 1987 Apr 16;316(16):985–992. doi: 10.1056/NEJM198704163161604. [DOI] [PubMed] [Google Scholar]
  7. Darras B. T., Koenig M., Kunkel L. M., Francke U. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet. 1988 Mar;29(3):713–726. doi: 10.1002/ajmg.1320290341. [DOI] [PubMed] [Google Scholar]
  8. Fischbeck K. H., Ritter A. W., Tirschwell D. L., Kunkel L. M., Bertelson C. J., Monaco A. P., Hejtmancik J. F., Boehm C., Ionasescu V., Ionasescu R. Recombination with pERT87 (DXS164) in families with X-linked muscular dystrophy. Lancet. 1986 Jul 12;2(8498):104–104. doi: 10.1016/s0140-6736(86)91634-x. [DOI] [PubMed] [Google Scholar]
  9. Forrest S. M., Cross G. S., Speer A., Gardner-Medwin D., Burn J., Davies K. E. Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature. 1987 Oct 15;329(6140):638–640. doi: 10.1038/329638a0. [DOI] [PubMed] [Google Scholar]
  10. Forrest S. M., Smith T. J., Cross G. S., Read A. P., Thomas N. S., Mountford R. C., Harper P. S., Geirsson R. T., Davies K. E. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet. 1987 Dec 5;2(8571):1294–1297. doi: 10.1016/s0140-6736(87)91192-5. [DOI] [PubMed] [Google Scholar]
  11. Gitschier J. Maternal duplication associated with gene deletion in sporadic hemophilia. Am J Hum Genet. 1988 Sep;43(3):274–279. [PMC free article] [PubMed] [Google Scholar]
  12. Harper P. S., Williams H., Thomas N., Sarfarazi M. Prenatal diagnosis of Duchenne dystrophy. Lancet. 1985 Apr 13;1(8433):872–872. doi: 10.1016/s0140-6736(85)92229-9. [DOI] [PubMed] [Google Scholar]
  13. Hartl D. L. Recurrence risks for germinal mosaics. Am J Hum Genet. 1971 Mar;23(2):124–134. [PMC free article] [PubMed] [Google Scholar]
  14. Higuchi M., Kochhan L., Olek K. A somatic mosaic for haemophilia A detected at the DNA level. Mol Biol Med. 1988 Feb;5(1):23–27. [PubMed] [Google Scholar]
  15. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  16. Monaco A. P., Bertelson C. J., Colletti-Feener C., Kunkel L. M. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet. 1987 Mar;75(3):221–227. doi: 10.1007/BF00281063. [DOI] [PubMed] [Google Scholar]
  17. Monaco A. P., Neve R. L., Colletti-Feener C., Bertelson C. J., Kurnit D. M., Kunkel L. M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 1986 Oct 16;323(6089):646–650. doi: 10.1038/323646a0. [DOI] [PubMed] [Google Scholar]
  18. Murphy E. A., Cramer D. W., Kryscio R. J., Brown C. C., Pierce E. R. Gonadal mosaicism and genetic counseling for X-linked recessive lethals. Am J Hum Genet. 1974 Mar;26(2):207–222. [PMC free article] [PubMed] [Google Scholar]
  19. Pearson P. L., Kidd K. K., Willard H. F. Report of the committee on human gene mapping by recombinant DNA techniques. Cytogenet Cell Genet. 1987;46(1-4):390–566. doi: 10.1159/000132487. [DOI] [PubMed] [Google Scholar]
  20. Wood S., McGillivray B. C. Germinal mosaicism in Duchenne muscular dystrophy. Hum Genet. 1988 Mar;78(3):282–284. doi: 10.1007/BF00291677. [DOI] [PubMed] [Google Scholar]
  21. den Dunnen J. T., Bakker E., Breteler E. G., Pearson P. L., van Ommen G. J. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature. 1987 Oct 15;329(6140):640–642. doi: 10.1038/329640a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES